Billionaires Holding FATE

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 20.6M
    Shares Outstanding

  • 80.0M
    Market Cap

News & Insights

ABOUT

FATE

Fate Therapeutics, Inc. provides biotechnology services. The Company researches and develops therapies to repair and regenerate body tissues with the help of stem cells. Fate Therapeutics conducts business in the United States.

Hedge funds hate Apple ... but love Facebook

NEWS

BRIEF-Berkshire Hathaway buys about 824,000 shares of Phillips 66

READ MORE